Subscribe To
Here's 1 stock that could join apple and amazon in the $1 trillion club that you might have overlooked
Unlike the current five stocks with $1 trillion market caps, AI isn't a major factor for this contender. Instead, its fortunes rely largely on treatin...
September 5, 2023, 9:12 am
‘miracle' weight-loss drug wegovy will not be issued through major insurers
Several prominent UK-based insurers including Aviva, Axa, and WPA will not cover the costs of the newly launched weight-loss drug, Wegovy, under their...
September 4, 2023, 10:08 am
Novo nordisk (nvo) posts upbeat data from heart failure study
Novo Nordisk (NVO) announces positive results from its label-expanding study of Wegovy to treat patients with heart failure and ...
August 25, 2023, 1:32 pm
Ozempic just got even better for novo nordisk stock
Ozempic is practically flying off the shelves to treat diabetes and obesity. The drug could also be use...
August 20, 2023, 8:30 am
Intuitive surgical: a significantly undervalued healthcare gem
Intuitive Surgical's stock price has declined 18% in the past four weeks, offering a more attractive valuation. The decline in stock price is due to m...
August 19, 2023, 9:16 pm
Aviva ceo says we need to look at benefits of anti-obesity drugs over a long period of time
Amanda Blanc, CEO of Aviva, discusses obesity drugs and their potential benefits....
August 16, 2023, 6:08 am
Lifemd: a derivative beneficiary of the demand for anti-obesity pharmaceuticals
LifeMD is positioned for rapid growth with the introduction of a weight management program and partnerships with Nutrisystem and Medifast. The company...
August 16, 2023, 2:33 am
Novo nordisk (nvo) rides on ozempic & wegovy amid rivalry
Novo Nordisk (NVO) continues to witness increasing demand for its diabetes and obesity care products li...
August 15, 2023, 10:55 am
The sell-off caused by wegovy and mounjaro in medtech stocks offers a huge opportunity
Wegovy and Mounjaro obesity and diabetes drugs are expected to have a significant impact on society and...
August 13, 2023, 11:31 pm
Novo nordisk to acquire obesity drug maker inversago pharma for up to $1 billion
Inversago's drugs use a different approach than most treatments in the obesity and diabetes space....
August 10, 2023, 11:56 am
Novo nordisk to acquire obesity drug developer inversago
Danish drug maker Novo Nordisk said on Thursday it would acquire Canadian company Inversago Pharma in a $1.07 billion deal including the development o...
August 10, 2023, 3:56 am
Wegovy-maker novo nordisk sales soar 30% on strong demand for its weight-loss drug
The Danish company's diabetes and obesity division performed particularly well, bolstered by interest i...
August 10, 2023, 2:07 am
Insurers face long road, high cost to cover obesity drugs after promising wegovy heart health data
There is likely a long way to go before the U.S. sees increased insurance coverage of obesity drugs, bu...
August 9, 2023, 12:19 pm
Eli lilly's stock jumps on promising weight-loss drug
Dr. Ezekiel Emanuel, fmr. Obama White House health policy advisor, joins 'Last Call' to talk the Eli Lilly's stock reaction to its weight-loss drug, r...
August 8, 2023, 9:04 pm
As obesity drugs help people eat less, these food companies could be the biggest losers
The growing popularity and use of anti-obesity medications will have far-reaching implications for the ...
August 8, 2023, 2:47 pm
Why eli lilly, novo nordisk, and viking therapeutics are on fire today
Novo Nordisk's popular weight loss drug significantly reduced the risk of heart attack or stroke in a late-stage trial. These data bode well for the <...
August 8, 2023, 11:45 am
The obesity drug revolution just got real
New data show Novo Nordisk's Wegovy reduces risk of heart attack and stroke, paving the way for greater insurance coverage....
August 8, 2023, 10:24 am
Novo nordisk shares pop after key trial data shows wegovy cuts risk of heart attack or stroke by 20%
Jared Holz, Mizuho healthcare sector strategist, joins 'Squawk Box' to discuss the impact of Novo Nordisk's weight-loss drug Wegovy cuts risk of heart...
August 8, 2023, 10:04 am
Novo nordisk weight loss drug impresses in heart trial
Novo Nordisk (NYSE:NVO) shares soared as the Danish pharma reported its new treatment Wegovy reduced heart problems well as weight in on ongoing trial...
August 8, 2023, 9:38 am
Wegovy's success in reducing cardio risk is ‘an important win,' and a ‘best-case scenario,' say wolfe analysts
The success of Novo Nordisk's NVO, +3.04% NOVO.B, +13.49% Wegovy in reducing cardiovascular events in obese adults is an important win for the ...
August 8, 2023, 8:02 am